MEK/ERK and PI3K/AKT pathways are often concurrently activated by separate genetic alterations in cancer cells but it was reported that ERK and AKT signaling cooperate to translationally regulate metastatic progression of certain types of cancer, e.g., colorectal cancer (Ye et al., 2013). The gene discussed is AKT1; the disease is colorectal cancer.